These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nonsurgical treatment of hepatocellular carcinoma. Llovet JM; Sala M; Bruix J Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079 [TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976 [TBL] [Abstract][Full Text] [Related]
8. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Vallone P; Catalano O; Izzo F; Siani A Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626 [TBL] [Abstract][Full Text] [Related]
10. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962 [TBL] [Abstract][Full Text] [Related]
11. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma]. Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718 [TBL] [Abstract][Full Text] [Related]
12. Chemoembolization and bland embolization: a critical appraisal. Befeler AS Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival. Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911 [TBL] [Abstract][Full Text] [Related]
16. [Primary liver and bile duct tumors: approach to conservative therapy]. Henne-Bruns D; Marks HG Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():343-7. PubMed ID: 9931637 [TBL] [Abstract][Full Text] [Related]
17. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC J Am Coll Surg; 2006 Oct; 203(4):411-20. PubMed ID: 17000383 [TBL] [Abstract][Full Text] [Related]
18. Strategies for the management of hepatocellular carcinoma. Schwartz M; Roayaie S; Konstadoulakis M Nat Clin Pract Oncol; 2007 Jul; 4(7):424-32. PubMed ID: 17597707 [TBL] [Abstract][Full Text] [Related]
19. [Nonsurgical therapy of hepatocellular carcinoma]. Allgaier HP; Galandi D; Olschewski M; Blum HE Praxis (Bern 1994); 2002 Aug; 91(35):1387-92. PubMed ID: 12233280 [TBL] [Abstract][Full Text] [Related]
20. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]